The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333), which would reauthorize the Hospital Preparedness Program at the current funding level of $385 million through fiscal year 2029. Among other provisions, the bill would require drug makers to notify the Food and Drug Administration when they anticipate a meaningful shortage and report who makes the active pharmaceutical ingredients in their drugs. AHA has urged Congress to at least double current annual funding for the HPP, which it called “vastly insufficient,” as well as address drug and device shortages.

Related News Articles

Perspective
When a natural disaster or emergency strikes, where is one of the first places people turn to? Their local hospital.That’s because hospitals and health systems…
Headline
Baxter announced that it is increasing the current U.S. allocation levels of its highest-demand IV fluids for direct customers from 40% to 60%, and for…
Headline
The Department of Health and Human Services Oct. 7 released a fact sheet on actions it is taking to help address the outbreak of Marburg virus in Rwanda. As of…
Headline
AHA President and CEO Rick Pollack Oct. 7 sent a letter to President Biden urging the Administration to take immediate actions to increase the supply of IV…
News
The increasing number of public health emergencies in the U.S., including mass violence incidents and natural disasters, highlight the need for enhanced…
Headline
The Federal Emergency Management Agency Sept. 30 lifted the immediate needs funding status for its disaster relief fund, as Congress provided additional…